欢笑 发表于 2025-3-23 11:37:10

Could Kinins Contribute to the Vasculoprotective Effect of Potassium Supplementation?,ssible mechanisms involved in vasculoprotection and have promoted their study in the laboratory animal. In humans they have led to the INTACT and MIDAS trials for calcium Channel blockers and to the PROTECT trial for angiotensin-converting enzyme (ACE) inhibitors.

BILK 发表于 2025-3-23 16:38:46

http://reply.papertrans.cn/32/3189/318845/318845_12.png

AVERT 发表于 2025-3-23 21:11:11

Clinical Relevance of Atrial Natriuretic Peptide,apan and in North America had independently sequenced and synthesized both a prohormone and major active constituent of atrial myocyte dense granules called atrial natriuretic peptide, polypeptide (ANP) or factor (ANF).

animated 发表于 2025-3-24 00:05:37

http://reply.papertrans.cn/32/3189/318845/318845_14.png

信条 发表于 2025-3-24 04:53:28

http://reply.papertrans.cn/32/3189/318845/318845_15.png

继承人 发表于 2025-3-24 08:03:07

scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading sci

大量杀死 发表于 2025-3-24 11:22:56

http://reply.papertrans.cn/32/3189/318845/318845_17.png

甜得发腻 发表于 2025-3-24 14:58:13

http://reply.papertrans.cn/32/3189/318845/318845_18.png

军火 发表于 2025-3-24 19:46:15

https://doi.org/10.1007/978-3-031-09875-8ssible mechanisms involved in vasculoprotection and have promoted their study in the laboratory animal. In humans they have led to the INTACT and MIDAS trials for calcium Channel blockers and to the PROTECT trial for angiotensin-converting enzyme (ACE) inhibitors.

Esophagitis 发表于 2025-3-25 01:03:16

http://reply.papertrans.cn/32/3189/318845/318845_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Experimental Hypertension and Therapeutic Progress: Vasodilation and Beyond; Bernward Garthoff,Andreas M. Knorr,Friedel Seuter Conference